OTCMKTS:MSLP MusclePharm (MSLP) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About MusclePharm Stock (OTCMKTS:MSLP) Get MusclePharm alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume26,442 shsMarket Capitalization$7 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MusclePharm Corporation was a sports nutrition company known for developing and marketing dietary supplements for athletes, fitness enthusiasts and other active consumers. Its product portfolio historically included protein powders, ready-to-drink beverages, pre-workout formulas, amino acid supplements, creatine products, vitamins and nutrition bars. The company sold products through specialty nutrition retailers, mass-market retailers, online channels and distributors. MusclePharm marketed its products primarily in the United States and also pursued international distribution, building brand recognition through sports, fitness and athlete-focused marketing. MusclePharm filed for Chapter 11 bankruptcy protection in 2020. In 2021, FitLife Brands acquired substantially all of MusclePharm’s operating assets and brand-related assets, including its product portfolio. As a result, MusclePharm’s business is now primarily associated with the brand and assets operated by FitLife Brands rather than with the former standalone operating company.AI Generated. May Contain Errors. Read More Receive MSLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MusclePharm and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MSLP Stock News HeadlinesMusclePharm and City Football Group Announce Multi-Year PartnershipJune 25, 2026 | finance.yahoo.comTry This Trick to Lose Weight and Gain Lean Muscle at the Same TimeOctober 28, 2024 | cnet.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 8 at 1:00 AM | Behind the Markets (Ad)The 5 best muscle rubs of 2024February 11, 2024 | businessinsider.com7 Healthy Habits to Decrease the Risk of Breast CancerNovember 2, 2023 | msn.comFitLife Brands swoops in for bankrupt MusclePharm assetsOctober 2, 2023 | msn.comUS Bankruptcy Court Approves FitLife's $18.5M Acquisition Of MusclePharmSeptember 28, 2023 | msn.comFitLife Brands to Acquire Substantially All of the Assets of MusclePharm CorporationSeptember 27, 2023 | benzinga.comSee More Headlines MSLP Stock Analysis - Frequently Asked Questions How were MusclePharm's earnings last quarter? MusclePharm Co. (OTCMKTS:MSLP) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.32. The business earned $50.48 million during the quarter, compared to analysts' expectations of $55 million. What other stocks do shareholders of MusclePharm own? Based on aggregate information from My MarketBeat watchlists, some other companies that MusclePharm investors own include Associated British Foods (ABF), Avation (AVAP), Alnylam Pharmaceuticals (ALNY), Altimmune (ALT), Accuray (ARAY), Alcoa (AA) and Alamos Gold (AGI). Company Calendar Today11/08/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MSLP CIK1415684 Webwww.musclepharm.com Phone(800) 292-3909FaxN/AEmployees20Year Founded2008Profitability EPS (Trailing Twelve Months)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.87 million Net Margins-38.51% Pretax Margin-38.52% Return on EquityN/A Return on Assets-169.56% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.23 Sales & Book Value Annual Sales$50.04 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.94) per share Price / BookN/AMiscellaneous Outstanding Shares33,390,000Free Float13,121,000Market Cap$7 thousand OptionableNot Optionable Beta-0.07 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:MSLP) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredThe IRS loophole Trump fought to preserve for retirees401(k) balances have reached record highs on a rising stock market and strong job growth. But traditional acco...American Hartford Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredA monthly income idea that does not require selling sharesA $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MusclePharm Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MusclePharm With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
